Markets
VTYX

Ventyx Biosciences Chief Financial Officer Martin Auster Steps Down

August 30, 2024 — 08:32 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Ventyx Biosciences, Inc. (VTYX), focused on inflammatory diseases, on Friday announced that Martin Auster has stepped down from his role as Chief Financial Officer with effect from August 30.

Roy Gonzales, the company's SVP of Finance, has assumed the roles of interim Principal Financial Officer and interim Principal Accounting Officer for SEC reporting purposes.

The company said that it has initiated a hunt for a new CFO.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

VTYX

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.